Skyline Medical (SKLN) Reports Q3 Loss of $0.32/Share

Skyline Medical (Nasdaq: SKLN) reported Q3 EPS of ($0.32), versus ($7.09) reported last year. Revenue for the quarter came in at $134.6 thousand, versus $85.8 thousand reported last year.

The Company had cash, cash equivalents and marketable securities of $1,211,366 as of September 30, 2016, compared with $4,856,232 as of December 31, 2015. The Company used $3,704,307 in cash to fund operations during the first nine months of 2016.

For earnings history and earnings-related data on Skyline Medical (SKLN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79